Evolent Health Inc
(STU:9EH)
€
13
-1.5 (-10.34%)
Market Cap: 1.62 Bil
Enterprise Value: 2.13 Bil
PE Ratio: 0
PB Ratio: 1.68
GF Score: 72/100 Evolent Health Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 08, 2021 / 09:30PM GMT
Robert Patrick Jones
Goldman Sachs Group, Inc., Research Division - VP
Okay. Good afternoon, everyone. My name is Bob Jones. I'm joined by my colleague, Jack Rogoff, and we cover the health care services and digital health space here at Goldman. Really excited for this next session with Evolent Health. Joining us from Evolent is Seth Blackley, Co-Founder and CEO, along with John Johnson, CFO. Welcome to you both for -- welcome to the conference. Thanks for being here today.
John Paul Johnson
Evolent Health, Inc. - CFO
Thanks for having us.
Seth Barrie Blackley
Evolent Health, Inc. - Co-Founder, CEO & Director
Thanks, guys.
Questions & Answers
Robert Patrick Jones
Goldman Sachs Group, Inc., Research Division - VP
So a couple of questions to start things off, a little bit bigger picture. Obviously, there's been a lot of evolution over the last 2 years at the company. We thought maybe just for starters, it'd be helpful for the audience to maybe reorient
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot